Search Results - David A. Morrow

Refine Results
  1. 1
    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease by David A. Morrow

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE>

    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE&... by David A. Morrow

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Future of Biomarkers in Acute Coronary Syndromes

    Future of Biomarkers in Acute Coronary Syndromes by David A. Morrow, Eugene Braunwald

    Published 2003
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  4. 4
    Unstable Angina

    Unstable Angina by Eugene Braunwald, David A. Morrow

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Evaluation of High-Sensitivity Assays for Cardiac Troponin

    Evaluation of High-Sensitivity Assays for Cardiac Troponin by David A. Morrow, Elliott M. Antman

    Published 2008
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  6. 6
    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes

    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes by James A. de Lemos, David A. Morrow

    Published 2002
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  7. 7
    Inflammatory Biomarkers in Acute Coronary Syndromes

    Inflammatory Biomarkers in Acute Coronary Syndromes by Ehrin J. Armstrong, David A. Morrow, Marc S. Sabatine

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity

    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity by Stacy E.F. Melanson, David A. Morrow, Petr Jarolı́m

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship?

    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship? by James A. de Lemos, David A. Morrow, Christopher R. deFilippi

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The Search for a Biomarker of Cardiac Ischemia

    The Search for a Biomarker of Cardiac Ischemia by David A. Morrow, James A. de Lemos, Marc S. Sabatine, Elliott M. Antman

    Published 2003
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  11. 11
    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction

    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American He... by Allan S. Jaffe, Fred S. Apple, David A. Morrow, Bertil Lindahl, Hugo A. Katus

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Identification of Genetic Variants Associated With Response to Statin Therapy

    Identification of Genetic Variants Associated With Response to Statin Therapy by Jessica L. Mega, David A. Morrow, Alison Brown, Christopher P. Cannon, Marc S. Sabatine

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35

    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 by Marc S. Sabatine, David A. Morrow, James A. de Lemos, Petr Jarolı́m, Eugene Braunwald

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial

    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial by Petr Jarolı́m, William B. White, Christopher P. Cannon, Qi Gao, David A. Morrow

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    COVID-19 for the Cardiologist

    COVID-19 for the Cardiologist by Deepak Atri, Hasan K. Siddiqi, Joshua Lang, Victor Nauffal, David A. Morrow, Erin A. Bohula

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Cardiogenic Shock After Acute Myocardial Infarction

    Cardiogenic Shock After Acute Myocardial Infarction by Marc D. Samsky, David A. Morrow, Alastair Proudfoot, Judith S. Hochman, Hölger Thiele, Sunil V. Rao

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS by David A. Morrow, Elliott M. Antman, Steven Snapinn, Carolyn H. McCabe, Pierre Théroux, Eugene Braunwald

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndro... by Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Paul M. Ridker, Eugene Braunwald

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A current review of COVID-19 for the cardiovascular specialist

    A current review of COVID-19 for the cardiovascular specialist by Joshua Lang, Xiaowen Wang, Filipe A. Moura, Hasan K. Siddiqi, David A. Morrow, Erin A. Bohula

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy by Stephen D. Wiviott, Christopher P. Cannon, David A. Morrow, Kausik K. Ray, Marc A. Pfeffer, Eugene Braunwald

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: